latest educational series
Raising the Bar in Atopic Dermatitis: Unpacking the practice-changing implications of the LEVEL UP study in AD
This educational video series provides expert commentary on the results and implications of Level Up, the first head-to-head trial in atopic dermatitis assessing upadacitinib (Rinvoq, AbbVie) at a starting dose of 15mg daily vs. dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals) at its labeled dose.
Taking a Closer Look at Prurigo Nodularis: An Expert-Led Video Series
Watch experts Drs. Raj Chovatiya and Matt Zirwas at an education symposium on diagnostic considerations for atopic deramtitis and prurigo nodularis and how clinical signs and itchn in these diseases are impacted by type 2 inflammation.

What’s Driving That Itch?
February 7, 2025

Doubling Down on Dark Spots With Lasers and Thiamidol
February 6, 2025


Pearls on Diagnosing and Treating Seb Derm With Dr. Karan Lal
February 6, 2025
latest conference coverage
Featured Videos